Inova acquires IN-PART, matchmaking platform for academia-industry collaboration

Published on Feb 8, 2022
Inova acquires IN-PART, matchmaking platform for academia-industry collaboration

Share this on Facebook Share this on Twitter Share this on LinkedIn

Watch the Q&A session

Lyon, France, 8 February 2022 – Inova announces the acquisition of IN-PART, a digital matchmaking platform dedicated to academia-industry collaboration. Along with the recent acquisition of Labiotech, this  move consolidates Inova’s position as a leader and pioneer in the digitalization of the biopharma partnering space, supported by the €60 million investment from global private equity firm Carlyle (NASDAQ: CG) and reaffirmation of a strong commitment by NextStage AM, in 2021. 

Inova supports more than 160 global clients, including many of the world’s largest pharmaceutical companies, and is at the forefront of digital transformation in biopharma collaborations. Inova’s flagship product, Inova Partnering Platform, serves as a collaborative tool used to manage all potential partnerships related to outsourced innovation to pharma and biotechs, enabling customers to source leads, execute transactions, and manage alliances and virtual events.   

IN-PART develops curated digital solutions that drive impact from research by streamlining relationships between industry professionals and the world of academic institutions. IN-PART's matchmaking platform, Connect, is used by 250+ universities and research institutes to find new partners for commercialization across more than 6,000 companies. The company’s bespoke scouting platform, Discover, is used by sector leaders to engage academics, TTOs, and research service departments in more than 1,500 institutes with specific R&D challenges or requirements.  

This acquisition is a major step forward for academia-industry partnering. While IN-PART will continue to service and expand its platforms for all research sectors, by joining forces with Inova, the company will gain access to Inova’s software infrastructure, as well as their market-leading teams in product and marketing. In turn, Inova clients will benefit from access to IN-PART search and discovery platforms, as well as leveraging best practice in matchmaking technology. By creating a stronger, more connected research ecosystem, this acquisition will ensure academic breakthroughs have an even greater impact on society.  

“ The Inova team is growing with talents and resources that are taking life science partnering to the next level. There is a growing consensus in the biopharma partnering world that academia is the next game-changer. However, our customers often report how difficult it is to navigate the extensive science produced by university groups. IN-PART has built an impressive digital solution to tackle this exact challenge and by acquiring them, we are now bringing our mission full-circle and including academia in the next gen partnering world. Together, we’re helping untapped science reach the market through smart partnering.”

Gilles Toulemonde
Gilles ToulemondeFounder and CEOInova

“ In Inova, we’ve found a great strategic fit across our technology base and close alignment in terms of company values and culture. It will give us access to a lot more resources and expertise for IN-PART to accelerate its growth and achieve its vision of connecting the academia-industry ecosystem, across all the research fields and sectors we work with. It’s a big moment for us and we're looking forward to the next part of our journey with the amazing team at Inova.”

Patrick Speedie
Patrick SpeedieCo-founder and Co-CEOIN-PART

“ It was clear from the start with Inova that there was synergy between our vision and approach. Inova provides clients with sector-leading Partnering software that fits perfectly with our matchmaking platform and search solution, Discover. The union of our companies, along with the exchange of expertise and technology across our teams will allow us to accelerate the pace at which we're helping to surface the next generation of treatments and technologies. ”

Robin Knight
Robin KnightCo-founder and DirectorIN-PART

Webinar replay

About Inova  

Inova is a cloud-based solution aimed at helping life science companies locate and manage their biopharma opportunities more efficiently. It offers a platform for partnering events, secure licensing and collaboration opportunities, and successful deal making and alliance management. Inova has over 125 employees and is headquartered in Lyon, France, with offices in New York, Denver, and Tokyo. Further information is available at Follow Inova on LinkedIn and Twitter.  

About IN-PART 

IN-PART provides digital matchmaking platforms for teams in academia and industry striving for greater positive impact through collaboration. Launched in 2014, IN-PART has offices in Sheffield and London, with a team of 50 employees, primarily from STEM backgrounds, who manage and curate their platforms. Further information is available at Follow IN-PART on LinkedIn and Twitter

Media contacts: 

Sarah Issa
Tel: +33 (0) 6 24 86 81 69

Alex Stockham 
+44 (0) 7474 887 855 

Further reading


What's new in Inova: July 2019

Welcome to our July newsletter! This month, we’re taking a look at reporting. We know that reporti...

Read more
Company News

Virtual partnering event launched to accelerate partnerships in the life sciences industry to fight against COVID-19

COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April...

Read more
Company News

Inova Reaps the Benefits of its New Business Model

Inova, software editor of a CRM dedicated to pharmaceutical companies, has followed software trends,...

Read more